What's happening now

Selecting the right partner for your hit-to-lead optimization project is crucial in advancing drug discovery. Key considerations include the partner’s expertise, highly standardized and accurate operations, track record in hit-to-lead optimization, and experience with similar targets or small molecules.

In the world of drug discovery, the search for new therapeutic agents that can alleviate suffering and improve the quality of life for millions of people is unending. In small molecule drug discovery, compound libraries form the foundation of these ventures. These libraries are treasure troves of potential drug candidates.

Discover the key role of effective data handling in pharmaceutical research with Pivot Park Screening Centre. Our state-of-the-art automation and screening infrastructure, coupled with ISO certifications and diverse data analysis techniques, ensure secure and quality data. Learn how our multidisciplinary team accelerates drug discovery, making us your trusted partner in early drug discovery efforts.

Explore the compound profiler, a cheminformatics reporting tool that gives you a wealth of information about the pharmacogenomics landscape associated with your compound hit list chemical space.

Explore the integral role of assay development in the drug discovery process. Dive into how advanced High-Throughput Screening assays streamline the identification and validation of novel chemical matter for small molecule therapeutics discovery.

At Pivot Park Screening Centre, we develop and carry out many different assay formats (biochemical, cellular, or biophysical assays). A